Head to Head Survey: Waystar (NASDAQ:WAY) & Firefly Neuroscience (NASDAQ:AIFF)

Waystar (NASDAQ:WAY) and Firefly Neuroscience (NASDAQ:AIFF) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Waystar and Firefly Neuroscience, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1	2	18	3	2.96
Firefly Neuroscience	1	0	0	0	1.00

Waystar presently has a consensus price target of $35.14, suggesting a potential upside of 51.22%. Given Waystar’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Waystar is more favorable than Firefly Neuroscience.

Profitability

This table compares Waystar and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Firefly Neuroscience	-565.40%	-94.68%	-73.51%

Institutional & Insider Ownership

5.0% of Firefly Neuroscience shares are owned by institutional investors. 3.5% of Waystar shares are owned by insiders. Comparatively, 6.9% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Waystar and Firefly Neuroscience”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10 billion	4.05	$112.09 million	$0.70	33.19
Firefly Neuroscience	$1.14 million	15.54	-$19.88 million	($0.63)	-1.80

Waystar has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Waystar has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500.

Summary

Waystar beats Firefly Neuroscience on 11 of the 15 factors compared between the two stocks.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.